NTNG2
Basic information
Region (hg38): 9:132162058-132244526
Previous symbols: [ "NTNG1" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (Moderate), mode of inheritance: AR
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 31372774; 31692205; 31668703 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTNG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 13 | ||||
missense | 28 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 0 | |||||
Total | 0 | 1 | 29 | 13 | 3 |
Variants in NTNG2
This is a list of pathogenic ClinVar variants found in the NTNG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-132166858-G-A | Likely benign (May 01, 2024) | |||
9-132166916-G-A | Inborn genetic diseases | Uncertain significance (Apr 22, 2024) | ||
9-132166965-G-A | Benign/Likely benign (Jul 01, 2024) | |||
9-132166978-C-T | Likely benign (Jul 01, 2022) | |||
9-132197958-C-G | Benign (Apr 01, 2023) | |||
9-132197959-G-A | Likely benign (Aug 09, 2018) | |||
9-132197994-G-A | Neurodevelopmental disorder • Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | Pathogenic/Likely pathogenic (Dec 23, 2019) | ||
9-132198024-C-T | Uncertain significance (Mar 01, 2024) | |||
9-132198071-T-G | Neurodevelopmental disorder • Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | Pathogenic/Likely pathogenic (Dec 23, 2019) | ||
9-132198100-C-G | Likely benign (Jul 01, 2022) | |||
9-132198125-C-CT | Global developmental delay;Stereotypical hand wringing;Areflexia;Generalized hypotonia • Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | Pathogenic (Dec 23, 2019) | ||
9-132198161-G-A | Inborn genetic diseases | Uncertain significance (Sep 13, 2023) | ||
9-132198174-T-C | Abnormality of the nervous system | Likely pathogenic (Jul 10, 2021) | ||
9-132198198-T-C | Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia • Neurodevelopmental disorder • Neurodevelopmental disorder with hypotonia, seizures, and absent language | Uncertain significance (May 29, 2020) | ||
9-132198223-C-T | Likely benign (Aug 01, 2023) | |||
9-132198299-C-G | Inborn genetic diseases | Uncertain significance (Mar 17, 2023) | ||
9-132198349-C-T | Likely benign (Mar 01, 2024) | |||
9-132198351-C-T | Neurodevelopmental disorder • Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | Likely pathogenic (Jun 01, 2022) | ||
9-132198367-C-G | Likely benign (Apr 01, 2023) | |||
9-132198399-G-T | Inborn genetic diseases | Uncertain significance (Dec 03, 2021) | ||
9-132198409-C-T | Likely benign (Mar 01, 2024) | |||
9-132198469-C-T | Benign/Likely benign (Mar 01, 2023) | |||
9-132198470-G-A | Inborn genetic diseases | Uncertain significance (Feb 16, 2023) | ||
9-132198490-C-T | Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | Benign (Sep 05, 2021) | ||
9-132198494-A-C | Uncertain significance (Oct 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTNG2 | protein_coding | protein_coding | ENST00000393229 | 7 | 82588 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00134 | 125643 | 0 | 5 | 125648 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.93 | 191 | 344 | 0.555 | 0.0000233 | 3434 |
Missense in Polyphen | 81 | 159.73 | 0.50711 | 1499 | ||
Synonymous | 1.14 | 134 | 152 | 0.882 | 0.0000114 | 1043 |
Loss of Function | 4.31 | 1 | 23.6 | 0.0423 | 0.00000110 | 252 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000109 | 0.0000924 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000342 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in controlling patterning and neuronal circuit formation at the laminar, cellular, subcellular and synaptic levels. Promotes neurite outgrowth of both axons and dendrites. {ECO:0000269|PubMed:21946559}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Axon guidance - Homo sapiens (human);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.246
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.315
- hipred
- Y
- hipred_score
- 0.774
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.730
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntng2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- axonogenesis;modulation of chemical synaptic transmission;postsynaptic specialization assembly;synaptic membrane adhesion;regulation of presynapse assembly
- Cellular component
- extracellular region;cytosol;plasma membrane;axon;intercellular bridge;anchored component of plasma membrane;Flemming body;Schaffer collateral - CA1 synapse;glutamatergic synapse;anchored component of presynaptic active zone membrane
- Molecular function
- molecular_function;protein binding